Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target By Investing.com - Stock Watch Index

Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target By Investing.com

October 10, 2025

Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target

Search

RECENT PRESS RELEASES

Bitcoin Miner Leads Two Health Care Stocks To New Highs

SWI Editorial Staff2025-10-10T12:46:29-07:00October 10, 2025|

Over 200 pounds of cannabis found in traffic stop on I-80 in Berkeley, CHP says

SWI Editorial Staff2025-10-10T12:44:56-07:00October 10, 2025|

Matson stock hits 52-week low at 91.42 USD By Investing.com

SWI Editorial Staff2025-10-10T12:43:43-07:00October 10, 2025|

SEI stock hits all-time high at 49.03 USD By Investing.com

SWI Editorial Staff2025-10-10T12:43:20-07:00October 10, 2025|

Conmed Corporation stock hits 52-week low at 45.0 USD By Investing.com

SWI Editorial Staff2025-10-10T12:42:55-07:00October 10, 2025|

Iff stock hits 52-week low at $59.87 By Investing.com

SWI Editorial Staff2025-10-10T12:42:32-07:00October 10, 2025|

Related Post